Trial | NCT00663286  Report issue

Title

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1399
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Study Started
Oct 31
2006
Primary Completion
Aug 31
2007
Last Update
Apr 22
2008
Estimate

Drug IDP-110

Topical application for 12 weeks

Drug Clindamycin

Topical application for 12 weeks

Drug Benzoyl peroxide

Topical application for 12 weeks

Drug Vehicle

Topical application for 12 weeks

1 Experimental

2 Active Comparator

3 Active Comparator

4 Placebo Comparator

Criteria 

Inclusion Criteria:

Presence of inflammatory and non-inflammatory lesions

Exclusion Criteria:

Dermatological conditions of the face other than acne that could interfere with clinical evaluations
Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
No Results Posted